Yet many people don’t seem to recognize this—and this is a missed opportunity. Helping people to rethink side effects as ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

The U.S. Food and Drug Administration recently green-lit new 2024-25 COVID-19 vaccinations ahead of the fall and winter seasons, when respiratory viruses spread more rapidly within communities.

Many healthy people have immunity from vaccines and previous infection. This is a KFF Health News story. The U.S. Food and Drug Administration has approved an updated COVID-19 shot for everyone 6 ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, ...

AND CORONARY ARTERY DISEASE. THEY ARE THE HIGH RISK GROUP. HOW EFFECTIVE IS THE VACCINE? IT’S VERY EFFECTIVE. SO FAR. YOU NEED ONLY ONE VACCINE, BUT STUDIES ARE ONGOING TO DECIDE WHETHER ...

One major reason why it has been difficult to develop an effective HIV vaccine is that the virus mutates very rapidly, ...

Clinicians and healthcare professionals should target adults aged 70 and over with underlying health conditions instead of the general population, when it comes to efforts to reduce spending and ...

Using health data to mimic a randomized controlled trial “We used real-world health data to estimate the vaccine’s effectiveness against mpox infection as rigorously as possible,” says ICES ...

A single dose of chikungunya vaccine is safe, effective, provides protection up to 2 years, and does not result in any long-term serious AEs related to vaccination.

Researchers have shown that they can generate a strong immune response against HIV with two doses of a vaccine given one week apart.